1-4 of 4
Marwan Kwok, MB, ChB
Close
Sort by
Journal Articles

Kinetics of CLL Subclonal Architecture: Spontaneous Disease Progression or Treatment-Induced Selection?

Ceri Oldreive, Nick Davies, PhD, Anna Skowronska, PhD, Marwan Kwok, MB ChB, MRCP, Guy Pratt, MDPhD, Paul Moss, Michael John Griffiths, BSc, Samuel Clokie, A. Malcolm R Taylor, Tatjana Stankovic
Journal: Blood
Blood (2015) 126 (23): 167.
https://doi.org/10.1182/blood.V126.23.167.167
Published: 2015
Journal Articles

ATR Inhibition Exacerbates Replication Stress in TP53 or ATM Deficient CLL Cells and Enhances Sensitivity to Chemotherapy and Targeted Therapy

Marwan Kwok, MB ChB, MRCP, Nicholas Davies, PhD, Angelo Agathanggelou, PhD, Edward Smith, BSc, Eva Petermann, PhD, Eliot Yates, BMedSc, Jeffrey Brown, PhD, Alan Lau, PhD, Tatjana Stankovic, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3340.
https://doi.org/10.1182/blood.V124.21.3340.3340
Published: 2014
Journal Articles

CLL Progression Is Associated with Increased Clonal Diversity and Replication Stress

Angelo Agathanggelou, PhD, Anna Skowronska, PhD, Nick Davies, PhD, Marwan Kwok, MB ChB, MRCP, Samuel Clockie, Mike Griffiths, Alexander Taylor, Tatjana Stankovic, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1977.
https://doi.org/10.1182/blood.V124.21.1977.1977
Published: 2014
Journal Articles

Minimal Residual Disease Is a Predictor for Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia (CLL) That Is Independent of the Type or Line of Therapy.

Marwan Kwok, MB, ChB, Andy C. Rawstron, PhD, Abraham Varghese, MB, ChB, MRCP, Peter Hillmen, MB, ChB, PhD
Journal: Blood
Blood (2009) 114 (22): 540.
https://doi.org/10.1182/blood.V114.22.540.540
Published: 2009